Please login to the form below

Not currently logged in


This page shows the latest migraines news and features for those working in and with pharma, biotech and healthcare.

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches”

Bob Bradway. “People suffering from migraine and their physicians have been waiting for years for an effective new therapy and they've reacted very well to Aimovig, ”he said. ... There’s no doubt that the rapid roll-out comes from pent-up demand

Latest news

More from news
Approximately 20 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    Published adherence in migraine-prophylaxis (as a comparable indication) indicates 92.6% adherent at one month, 40.7% at two months, 30.9% at three months, 24.8% at four months,

  • Deal Watch January 2018

    III CGRP antibody for the treatment of migraine.

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • The cultural construction of illness The cultural construction of illness

    Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her

  • Ditch the data? Ditch the data?

    Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.

More from intelligence
Approximately 2 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Biofeedback Equipment Market to Make Great Impact in Near Future by 2027

    Biofeedback equipment is used to treat chronic pain, migraine headache, tension headache, high blood pressure and urinary incontinence. ... Biofeedback equipment used in treatments such as urinary and fecal incontinence, migraine, post-traumatic disorder,

  • Europe to Remain Second Largest Market for Medical Device Technologies, Finds FMI Study

    These technologies include MelaFind opticalinstrument for cutting the cancer cell of melanoma skin cancer, electronic aspirin utilized to relief from migraines, needle free diabetes care instrument to detect the glucose level,

  • Hanson Zandi

    Migraine. Monoclonal antibodies. Respiratory. Women’s Health.

  • Double Communiqué award win for 90TEN

    The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:

  • What it takes to win at Cannes Health Lions

    As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for  Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...